...
...

sun pharma news

Winds of change in Sun Pharma's $11.75 billion Organon acquisition announcement

India's Sun Pharmaceutical on April 27 said it had agreed to buy women's healthcare firm Organon in a deal that values the US drugmaker at $11.75 billion.
Published on Apr 28, 2026 08:25 am IST

Sun Pharma shares climb nearly 4% post earnings announcement

Sun Pharma said its board has approved an interim dividend of 11 per equity share of Re 1 for the financial year 2025-26.
Published on Feb 01, 2026 10:27 am IST

Sun Pharma's Taro recalls over 17,000 units of antifungal shampoo in US

The company is recalling the affected lot due to "Failed Impurity/Degradation specifications," the USFDA stated.
Published on Dec 25, 2025 04:29 pm IST

Sun Pharma's Q2 profit rises, profitability takes a hit on declining US sales

Sun Pharma's US sales dipped 4.1% year-on-year to 4,400 crore in July-September 2025.
Updated on Nov 05, 2025 04:55 pm IST

Sun Pharma at risk from Trump's latest tariffs, impact on Indian firms minimal

Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US
Published on Sept 28, 2025 12:48 pm IST

Trump Tariff On Pharma Proves Costly For Asian Drugmakers, EU Peers Not So Much

India is largely an exporter of generic drugs to the US, which do not fall under the purview of Trump tariff on pharma imports.
Updated on Sept 26, 2025 04:45 pm IST

The impact of Trump tariff on Indian Pharma is limited at best

India makes and exports low-cost generic drugs to the US and not branded, patented drugs, which have come under 100% US tariffs on pharma.
Updated on Sept 27, 2025 09:03 am IST

Decline in pharma stocks today due to Trump tariff is largely ‘sentimental’

The share prices of Indian pharma companies were hit on Friday after Trump's 100 per cent tariff announcement.
Updated on Sept 27, 2025 12:04 am IST

Sun Pharma drops 5% after Donald Trump slaps 100% tariff on branded pharma

The logo of Sun Pharma installed on the facade of its corporate office in Mumbai.
Updated on Sept 26, 2025 10:09 am IST

How Trump's 100% tariff on pharma imports could impact India. Explained

Donald Trump has announced that he will put import taxes of 100 per cent on pharmaceutical drugs.
Updated on Sept 27, 2025 12:00 am IST

Sun Pharma to buy US firm with new skin cancer treatment product for $355 mn

A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai, India, November 14, 2017.
Published on Mar 10, 2025 05:42 pm IST

Indian pharma stocks fall after Donald Trump plans 25% tariff

Trump added that he wanted to provide some time for drug and chip makers to set up US factories so they could avoid tariffs.
Published on Feb 19, 2025 11:23 am IST

Who is Vidhi Shanghvi? Heir to 4 lakh crore pharma empire

Vidhi Shanghvi is also the head of Consumer Healthcare, Nutrition, and India Distribution for Sun Pharma
Updated on Dec 19, 2024 02:15 pm IST

Union Budget 2024 wish list: Pharma tax benefits, IPR, infra status for hotels

Finance Minister Nirmala Sitharaman (PTI)
Published on Jul 07, 2024 10:34 pm IST

Why Sun Pharma is recalling 55,000 bottles of generic gout medication from US?

FILE PHOTO: A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai, India, November 14, 2017. REUTERS/Shailesh Andrade/File Photo
Published on Mar 10, 2024 01:37 pm IST

Sun Pharma Q2 results: Profit rises 5% on strong sales of generic cancer drug

Sun Pharmaceutical
Updated on Nov 01, 2023 03:02 pm IST

Why Dr Reddy's and Sun Pharma are recalling certain products from US market

Representative Image
Published on Dec 04, 2022 01:17 pm IST

Cancer Daily Horoscope for February 28: Astro prediction for love life

It is high time that you set your intentions and make a few plans.
Published on Feb 28, 2022 12:26 am IST

Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief

Nitin Gadkari also appealed to the people of Nagpur to follow all Covid-19 prevention protocols.. (PTI Photo/R Senthil Kumar)
Published on Apr 11, 2021 11:45 am IST

India's biggest drugmaker profit beats estimates as sales rise

India’s largest drugmaker, Sun Pharma is eyeing key stake.mint
Published on Jan 29, 2021 03:52 pm IST

Sun Pharma’s profit rises amid increase in routine check-ups, drug prescriptions

Sun Pharma’s shares were trading almost 3% higher at 3 p.m. in Mumbai on Tuesday, pushing this year’s increase to 11.5%. The benchmark S&P Sensex has slipped 2.4% so far this year.
Published on Nov 03, 2020 03:59 pm IST

Sun Pharma latest to sell Covid-19 drug favipiravir in India

Sun’s version of favipiravir, to be called FluGuard, will cost 35 rupees (47 cents) per 200 mg tablet, making it the cheapest version available. Stocks will be available from this week.
Published on Aug 04, 2020 03:33 pm IST

Sun begins next stage of potential Covid-19 drug trial

The clinical trial will be conducted on 210 subjects across 12 centres in India for a duration of 10 days, the results of which are expected in October.
Published on Jun 06, 2020 04:41 am IST

Sun Pharma testing plant-based drug as potential Covid-19 treatment

The company said the trial will be conducted across 12 centers in India in 210 patients and a human safety study of the drug has been completed.
Updated on Jun 06, 2020 01:43 am IST

Sun Pharma to conduct clinical trial of pancreatitis drug in Covid-19 patients

The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020. (Photo by Himanshu Vyas/ Hindustan Times)
Published on May 29, 2020 03:48 pm IST

Sensex tanks nearly 400 pts in opening session; Nifty near 11,700

According to traders, besides weak cues from global markets amid rising concerns over coronavirus outbreak beyond China, heavy foreign fund outflow too weighed on market sentiment here. (ANI photo)
Updated on Feb 26, 2020 09:53 am IST

Sensex, Nifty edge lower as investors lock in profits

Shares inched lower on Tuesday, led by losses in information technology stocks
Updated on Dec 10, 2019 10:58 am IST

Sensex falls over 100 points; Sun Pharma rallies 5 percent

Market benchmark BSE Sensex dropped over 100 points in early trade on Wednesday
Updated on Nov 06, 2019 10:28 am IST

Sensex, Nifty ends flat, healthcare stocks fall 2%

A man looks at a screen across a road displaying the Sensex on the facade of the Bombay Stock Exchange (BSE) building in Mumbai, India, June 29, 2015. REUTERS/Danish Siddiqui/File Photo
Updated on Jan 18, 2019 04:57 pm IST

Sensex rallies over 300 points, Nifty reclaims 10,800 level

People look at a screen displaying the Sensex results on the facade of the Bombay Stock Exchange (BSE) building in Mumbai.
Updated on Dec 28, 2018 10:09 am IST